OptiViVax Consortium Annual Meeting 2025 in Cork, Ireland

The OptiViVax Consortium held its annual meeting on 3-4 June 2025 in Cork, Ireland. This event brought together project partners to share exciting advances, laying groundwork across the vaccine research process, including innovations in:

• new challenge models encompassing the entire Plasmodium vivax life cycle;

• blood-stage antigen discovery approaches, delivery technologies, and vaccine adjuvantation;

• novel assays to assess transmission-blocking and liver-stage inhibition for future vaccine candidates.

Many thanks to all OptiViVax researchers and scientific advisors for the constructive dialogue.

The project is supported by funding from the European Commission, the UK (UKRI) and Swiss (SERI) governments.

Scientific Speakers: Andrew Duncan, Tessa Geraedts, Prasun Kundu, Konstantinos Koussis, Valérie Soulard, Mimi Hou, Dohwan Ahn, Roland Ventura, Eyob Addise.

Technical Work Package Leads, Partners, & ISAC: Benjamin Mordmueller, Simon Draper, Angela Minassian, Julian Rayner, Robert Moon, Valérie Soulard, Anne Moore, Roland Ventura, Fitsum Girma, Rick King (ISAC).

Project Partners: Radboudumc, University of Oxford, University of Cambridge, London School of Hygiene and Tropical Medicine, INSERM, University College Cork, Vaccine Formulation Institute, Armauer Hansen Research Institute, and GIMM.

For more information about the OptiViVax Consortium, please click here.